Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization f
about
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue SarcomaPazopanib in the management of advanced soft tissue sarcomasEfficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic reviewUpdate on clinical research and state of the art management of patients with advanced sarcomas and GISTREGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis.Patient-generated health data: a pathway to enhanced long-term cancer survivorship.Cost-effectiveness of pazopanib in advanced soft tissue sarcoma in the United kingdom.Phase II studies in soft tissue sarcoma: time for reappraisal.Advances in the targeted therapy of liposarcoma.Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approachesImmunotherapies in sarcoma: Updates and future perspectivesA cluster-randomised, controlled proof-of-concept study to explore the feasibility and effect of a patient-directed intervention on quality of life in patients with advanced soft tissue sarcoma.Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review.Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations.A Case of Uterine Leiomyosarcoma with Long-Term Disease Control by Pazopanib.Health-related quality of life of cancer patients with peripherally inserted central catheter: a pilot study.
P2860
Q26741817-940E5ED0-4119-4D3C-9B85-4438599968CEQ26746205-C836CC6A-7E50-4CE3-BB0C-3FFF874D14D3Q26822530-11138A16-2388-487D-9427-29310DAC999EQ28073290-BB733E9F-3EC5-44A5-9EB1-9E94EBD078ADQ30491125-8A3833E7-476C-451F-86A6-6B26906478DDQ31034369-5976679B-2C5E-4F82-A23B-93F10E738913Q33850011-C1648129-A2F7-4594-98AB-86FE2759440DQ34143849-15963E54-F279-4641-B225-E459713310FAQ34952133-C7F0E7A8-B7BA-48F6-81A2-AB80A1AD5B48Q36144210-EA236F7E-5A76-43AE-90F8-4BB13305CA52Q37743055-585C3857-1ECA-44E3-AF86-2CFCD215F571Q38699278-5A60411D-FE3C-4BF0-BC8F-C3E4600E3A90Q38936104-A3434876-9E60-45A4-ACE7-DA41AF3578ECQ41105379-044EE0FB-5D6D-48F2-964A-648908AEA9B6Q42279324-18A0659D-4F4E-4BC3-8295-66162F2A1A76Q47754081-4EF86BAA-19BF-4D7A-AD2D-5D10E500E938
P2860
Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization f
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Health-related quality-of-life ...... rapy-a European Organization f
@en
type
label
Health-related quality-of-life ...... rapy-a European Organization f
@en
prefLabel
Health-related quality-of-life ...... rapy-a European Organization f
@en
P2093
P2860
P50
P356
P1433
P1476
Health-related quality-of-life ...... rapy-a European Organization f
@en
P2093
Corneel Coens
Ian Judson
Iwona Lugowska
Judith B Prins
Rachel A Hodge
Sandrine Marreaud
Sant P Chawla
Saskia Litière
Stephanie C Manson
Winette T A van der Graaf
P2860
P304
P356
10.1002/CNCR.29426
P407
P577
2015-05-29T00:00:00Z